Biogen BIIB
NASDAQ BIIB
$217.62 +3.27 (+1.53%)
As of: Aug 21, 2026 · 2:13 PM EDT

Biogen (BIIB) Gross Margin (2009 - 2026)

Biogen (BIIB) posted quarterly Gross Margin of 71.6% for Q2 2026, down 553.0% year-over-year from 15.81% in Q2 2025, and down 2.34% quarter-over-quarter from 73.32% in Q1 2026.

Biogen (BIIB) Gross Margin (2009 - 2026) Analysis & Trends

Biogen's Gross Margin history runs 18 years deep, the most recent figure standing at 71.6% for Q2 2026.

  • In Q2 2026, Gross Margin fell 553.0% year-over-year to 71.6%; the TTM figure through Jun 2026 stood at 73.99% (down 143.0% YoY), while the FY2025 annual figure was 75.69%, down 43.0% from the prior year.
  • Gross Margin for Q2 2026 stood at 71.6%, down from 73.32% in the prior quarter.
  • The five-year high for Gross Margin was 93.55% in Q4 2022, with the low at 71.6% in Q2 2026.
  • The 5-year median for Gross Margin is 76.28% (2024), against an average of 78.53%.
  • The sharpest annual moves came in 2022 and 2024: Gross Margin surged 689 bps in 2022, then tumbled 1690 bps in 2024.
  • Biogen's Gross Margin stood at 93.55% in 2022, then retreated by 0 bps to 93.13% in 2023, then declined by 18 bps to 76.23% in 2024, then grew by 3 bps to 78.26% in 2025, then fell by 9 bps to 71.6% in 2026.
  • Business Quant data shows BIIB's Gross Margin at 71.6% in Q2 2026, 73.32% in Q1 2026, and 78.26% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 652.91 Bn 632.15 Bn 17.26 Bn 68.19%
2 AbbVie 469.40 Bn 462.83 Bn 12.70 Bn 74.74%
3 Merck 375.75 Bn 368.61 Bn 12.21 Bn 73.54%
4 Novartis Ag 303.13 Bn 295.44 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.65 Bn 252.75 Bn 12.86 Bn 83.60%
6 Amgen 236.26 Bn 222.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 182.12 Bn 178.95 Bn 6.22 Bn 79.76%
8 Pfizer 159.46 Bn 147.76 Bn 10.94 Bn 72.78%
9 Gsk 106.21 Bn 102.04 Bn 8.24 Bn 73.05%
10 Biogen 32.12 Bn 30.84 Bn 1.96 Bn 71.60%

Historic Data

Download Data
DateValue
Jun 30, 2026 71.60%
Mar 31, 2026 73.32%
Dec 31, 2025 78.26%
Sep 30, 2025 73.39%
Jun 30, 2025 77.13%
Mar 31, 2025 74.11%
Dec 31, 2024 76.23%
Sep 30, 2024 74.10%
Jun 30, 2024 77.85%
Mar 31, 2024 76.33%
Dec 31, 2023 93.13%
Sep 30, 2023 73.93%
Jun 30, 2023 75.87%
Mar 31, 2023 73.09%
Dec 31, 2022 93.55%
Sep 30, 2022 81.28%
Jun 30, 2022 81.31%
Mar 31, 2022 89.14%
Dec 31, 2021 94.00%
Sep 30, 2021 81.58%